Search Results - "TSUDA, HITOSHI"

Refine Results
  1. 1

    Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray by Saito, Naoya, Matsuo, Tsukasa, Tsuda, Hitoshi, Yokota, Hiroyuki, Okada, Hisatake

    Published in PloS one (15-05-2024)
    “…HER2 expression in breast cancer is evaluated to select patients for anti-HER2 therapy. With the advent of newly approved HER2-targeted drugs for low HER2…”
    Get full text
    Journal Article
  2. 2

    MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma by Sato, Kimiya, Miyamoto, Morikazu, Takano, Masashi, Tsuda, Hitoshi

    “…Endometrial carcinoma is one of the most common gynecological cancers. MicroRNA-21 (miR-21) is the most consistently overexpressed miRNA in almost all human…”
    Get full text
    Journal Article
  3. 3

    Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma by Inoue, Jun, Kishikawa, Masahiro, Tsuda, Hitoshi, Nakajima, Yasuaki, Asakage, Takahiro, Inazawa, Johji

    Published in Cancer science (01-07-2021)
    “…The metabolism in tumors is reprogrammed to meet its energetic and substrate demands. However, this metabolic reprogramming creates metabolic vulnerabilities,…”
    Get full text
    Journal Article
  4. 4

    Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors by Miyai, Kosuke, Yonekura, Yuiko, Ito, Keiichi, Matsukuma, Susumu, Tsuda, Hitoshi

    “…We previously demonstrated a genetic evidence of the progression from seminoma to embryonal carcinoma in mixed testicular germ cell tumors (TGCTs). This…”
    Get full text
    Journal Article
  5. 5

    ARID1A expression in gastric adenocarcinoma:Clinicopathological significance and correlation with DNA mismatch repair status by Inada, Ryo, Sekine, Shigeki, Taniguchi, Hirokazu, Tsuda, Hitoshi, Katai, Hitoshi, Fujiwara, Toshiyoshi, Kushima, Ryoji

    Published in World journal of gastroenterology : WJG (21-02-2015)
    “…AIM:To analyze the mismatch repair(MMR)status and the ARID1A expression as well as their clinicopathological significance in gastric adenocarcinomas.METHODS:We…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma by Miyai, Kosuke, Kawamura, Kazuki, Ito, Keiichi, Matsukuma, Susumu, Tsuda, Hitoshi

    Published in BMC cancer (18-07-2022)
    “…Background Periostin is an extracellular matrix protein that has been known to be implicated in fibrillogenesis and cell migration, including cancer…”
    Get full text
    Journal Article
  8. 8

    Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer by Miyai, Kosuke, Mikoshi, Ayako, Hamabe, Fumiko, Nakanishi, Kuniaki, Ito, Keiichi, Tsuda, Hitoshi, Shinmoto, Hiroshi

    Published in Modern pathology (01-10-2019)
    “…The current study aimed to investigate the plausible histopathological factors that affect the detectability of prostate cancers on multiparametric magnetic…”
    Get full text
    Journal Article
  9. 9

    Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum by Matsubara, Akiko, Sekine, Shigeki, Kushima, Ryoji, Ogawa, Reiko, Taniguchi, Hirokazu, Tsuda, Hitoshi, Kanai, Yae

    Published in The Journal of pathology (01-03-2013)
    “…Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal‐type, foveolar‐type and pyloric…”
    Get full text
    Journal Article
  10. 10

    NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma by Yoshida, Akihiko, Sekine, Shigeki, Tsuta, Koji, Fukayama, Masashi, Furuta, Koh, Tsuda, Hitoshi

    Published in The American journal of surgical pathology (01-07-2012)
    “…Ewing sarcoma is a high-grade round cell sarcoma that affects bones and soft tissues in children and young adults. Its diagnosis can be challenging, and the…”
    Get full text
    Journal Article
  11. 11

    Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer by Oda, Katsutoshi, Aoki, Daisuke, Tsuda, Hitoshi, Nishihara, Hiroshi, Aoyama, Hisanori, Inomata, Hyoe, Shimada, Muneaki, Enomoto, Takayuki

    Published in Cancer science (01-01-2023)
    “…The association between germline BRCA1 and BRCA2 pathogenic variants (mutations: gBRCAm) and ovarian cancer risk is well established. Germline testing alone…”
    Get full text
    Journal Article
  12. 12

    Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus by Sato, Kimiya, Miyamoto, Morikazu, Takano, Masashi, Tsuda, Hitoshi

    “…The expression of L-type amino acid transporter 1 (LAT1) has been described to play essential roles in cancer cell growth and survival. To determine the…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma by Sato, Kimiya, Miyamoto, Morikazu, Takano, Masashi, Furuya, Kenichi, Tsuda, Hitoshi

    “…L-type amino acid transporter 1 (LAT1) is a Na + -independent neutral amino acid transporter that plays a key role in cancer cell growth and survival. To…”
    Get full text
    Journal Article
  16. 16

    PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma by Yamamoto, Sohei, Tsuda, Hitoshi, Takano, Masashi, Iwaya, Keichi, Tamai, Seiichi, Matsubara, Osamu

    Published in The Journal of pathology (01-10-2011)
    “…Clear cell adenocarcinoma (CCA), a highly lethal histological subtype of ovarian carcinoma, is a type of human cancer with a high frequency of activating…”
    Get full text
    Journal Article
  17. 17

    Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays by Shiraishi, Takehiro, Shinto, Eiji, Nearchou, Ines P., Tsuda, Hitoshi, Kajiwara, Yoshiki, Einama, Takahiro, Caie, Peter D., Kishi, Yoji, Ueno, Hideki

    “…Mesothelin (MSLN) is a cell surface glycoprotein present in many cancer types. Its expression is generally associated with an unfavorable prognosis. This study…”
    Get full text
    Journal Article
  18. 18

    Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System by Horiguchi, Akio, Shinchi, Masayuki, Nakamura, Akiko, Wada, Takatsugu, Ito, Keiichi, Asano, Tomohiko, Shinmoto, Hiroshi, Tsuda, Hitoshi, Ishihara, Miya

    Published in Urology (Ridgewood, N.J.) (01-10-2017)
    “…To investigate a link between the appearance of photoacoustic imaging (PAI) and microvasculature in prostate cancer and to assess the feasibility of PAI for…”
    Get full text
    Journal Article
  19. 19

    Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon Cancer by Shinto, Eiji, Yoshida, Yuichiro, Kajiwara, Yoshiki, Okamoto, Koichi, Mochizuki, Satsuki, Yamadera, Masato, Shiraishi, Takehiro, Nagata, Ken, Tsuda, Hitoshi, Hase, Kazuo, Kishi, Yoji, Ueno, Hideki

    Published in Annals of surgical oncology (01-10-2020)
    “…Background Tumor budding, a microscopic finding of dedifferentiation at the invasive margin, has been reported as a definite prognostic marker in colon cancer…”
    Get full text
    Journal Article
  20. 20

    Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics by Yoshida, Akihiko, Ushiku, Tetsuo, Motoi, Toru, Shibata, Tatsuhiro, Beppu, Yasuo, Fukayama, Masashi, Tsuda, Hitoshi

    Published in Modern pathology (01-09-2010)
    “…Parosteal osteosarcoma and low-grade central osteosarcoma are two types of low-grade osteosarcoma that show similar clinical behaviors, histological features,…”
    Get full text
    Journal Article